Quality of health care of atopic eczema in Germany: Results of the national health care study AtopicHealth

Journal of the European Academy of Dermatology and Venereology

Volumn 28, Issue 6, 2014, Pages 719-726

  Langenbruch, A ^a   Radtke, M ^a   Franzke, N ^a   Ring, J ^b   Foelster Holst, R ^c   Augustin, M ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; EMOLLIENT AGENT;

ADULT; AGED; ARTICLE; ATOPIC DERMATITIS; DISEASE SEVERITY; FEMALE; GERMANY; HEALTH CARE QUALITY; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; QUALITY OF LIFE; SKIN PRURITUS; CROSS-SECTIONAL STUDY; DERMATITIS, ATOPIC; PROSPECTIVE STUDY; QUESTIONNAIRE;

ADULT; CROSS-SECTIONAL STUDIES; DERMATITIS, ATOPIC; FEMALE; GERMANY; HUMANS; MALE; PROSPECTIVE STUDIES; QUALITY INDICATORS, HEALTH CARE; QUALITY OF HEALTH CARE; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 84900512201     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/jdv.12154     Document Type: Article

References (28)

1. Barbeau M, Bpharm H,. Burden of atopic dermatitis in Canada. Int J Dermatol 2006; 45: 31-36.
2. Krakowski A, Eichenfield L, Dohil M,. Management of atopic dermatitis in the pediatric population. Pediatrics 2008; 122: 812-824.
3. McKenna S, Doward L,. Quality of life of children with atopic dermatitis and their families. Curr Opin Allergy Clin Immunol 2008; 8: 228-231.
4. Carlsten C, Dimich-Ward H, Ferguson A, et al,. Atopic dermatitis in a high-risk cohort: natural history, associated allergic outcomes, and risk factors. Ann Allergy Asthma Immunol 2013; 110: 24-28.
5. Bingefors K, Svensson A, Isacson D, et al,. Self-reported lifetime prevalence of atopic dermatitis and co-morbidity with asthma and eczema in adulthood: a poplulation-based cross-sectional survey. Acta Derm Venereol 2012; Dec 27. doi: 10.2340/00015555-1522. [Epub ahead of print]
6. Eichenfeld LF, Ellis CN, Mancini AJ, et al,. Atopic dermatitis: epidemiology and pathogenesis update. Semin Cutan Med Surg 2012; 31: S3-S5.
7. Turner MJ, Travers JB, Kaplan MH,. T helper cell subsets in the development of atopic dermatitis. J Drugs Dermatol 2012; 11: 1174-1178.
8. Chernyshov PV, Jirakova A, Ho RC, et al,. An International Multicenter Study on quality of life and family quality of life in children with atopic dermatitis. Indian J Dermatol Venereol Leprol 2013; 79: 52-58.
9. Chren M, Lasek R, Quinn L, et al,. Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness. J Invest Dermatol 1996; 107: 707-713.
10. Augustin M, Lange S, Wenninger K, et al,. Validation of a comprehensive freiburg life quality assessment (FLQA) core questionnaire and development of a threshold system. Eur J Dermatol 2004; 14: 107-113.
11. Augustin M, Zschocke I, Seidenglanz K, et al,. Validation and clinical results of the FLQA-d, a quality of life questionnaire for patients with chronic skin diseases. Dermatol Psychosom 2000; 1: 12-17.
12. Amaral CS, March Mde F, Sant'Anna CC,. Quality of life in children and teenagers with atopic dermatitis. An Bras Dermatol 2012; 87: 717-723.
13. Schmitt J,. Health services research the example of atopic dermatitis. Hautarzt 2001; 62: 178-188.
14. Schmitt J, Williams H, HOME Development Group. Harmonising outcome measures for Eczema (HOME). Report from the First International Consensus Meeting (HOME 1), 24 July 2010, Munich, Germany. Br J Dermatol 2010; 163: 1166-1168.
15. Schmitt J, Spuls P, Boers M, et al,. Towards global consensus on outcome measures for atopic eczema research: results of the HOME II meeting. Allergy 2012; 67: 111-117.
16. Ring J, Alomar A, Bieber T, et al,. Guidelines for treatment of atopic eczema (atopic dermatitis) Part I. J Eur Acad Dermatol Venereol 2012; 26: 1045-1060.
17. Ring J, Alomar A, Bieber T, et al,. Guidelines for treatment of atopic eczema (atopic dermatitis) Part II. J Eur Acad Dermatol Venereol 2012; 26: 1176-1193.
18. Augustin M, Werfel T, Aberer W, et al,. Neurodermitits S2-Leitlinie. J Dtsch Dermatol Ges 2009; 7: S1-S46.
19. Augustin M, Reich K, Reich C, et al,. Quality of psoriasis care in Germany-results of the National Study PsoHealth 2007. J Dtsch Dermatol Ges 2008; 6: 640-645.
20. Augustin M, Reich C, Schaefer I, et al,. Development and validation of a new instrument for the assessment of patient-defined benefit in the treatment of Acne. J Dtsch Dermatol Ges 2008; 6: 113-120.
21. Augustin M, Radtke M, Zschocke I, et al,. The patient benefit index: a novel approach in patient-defined outcomes measurement for skin diseases. Arch Dermatol Res 2009; 301: 561-571.
22. Finlay A, Khan G,. Dermatology life quality index (DLQI)-a simple practical measure or routine clinical use. Clin Exp Dermatol 1994; 19: 210-216.
23. Augustin M, Amon U, Braathen L, et al,. Erfassung von Lebensqualität in der Dermatologie. J Dtsch Dermatol Ges 2004; 2: 802-806.
24. Augustin M, Kruger K, Radtke M, et al,. Disease severity, quality of life and health care in plaque-type psoriasis: a multicenter cross-sectional study in Germany. Dermatology 2008; 216: 366-372.
25. Baerlocher MO, O'Brien J, Newton M, et al,. Data integrity, reliability and fraud in Medical Research. Eur J Intern Med 2010; 21: 40-45.
26. Rosnow R, Rosenthal R,. Computing contrasts, effect sizes, and counternulls on other people's published data: general procedures for research consumers. Psychol Methods 1996; 1: 331-340.
27. Cohen J,. Statistical Power Analysis for the Behavioral Sciences, 2nd edn. Lawrence Earlbaum Associates, Hillsdale, NJ, 1988.
28. Radtke M, Reich K, Blome C, et al,. Evaluation of quality of care and guideline-compliant treatment in psoriasis. Development of a new system of quality indicators. Dermatology 2009; 219: 54-58.